Market Overview

Catalyst Pharma Shares Pop After Cancelling Public Offering


Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) shares are trading higher after the news emerged that the company will not proceed with the previously announced public offering.

The company believes that the culmination of an offering at the current market price of the common stock is not in its best interest.

Catalyst Pharmaceuticals had previously reported an 8 million share common stock offering.

Shares were trading up 9.9% at $6.75 in Friday’s pre-market session. On Thursday following news of the proposed offering, shares had declined 17.50% to $6.13 per share.

The stock has a 52-week range between $7.67 and $1.85.

Related Links:

Kroger Reports Q2 Earnings Beat

Viavi Raises Q1 Guidance, Announces $200M Buyback

Posted-In: News Offerings


Related Articles (CPRX)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

24 Stocks Moving in Friday's Pre-Market Session

California Cannabis Legislation In 2019: A Look At What Passed, Stalled In Sacramento